Orthofix(US:OFIX) GlobeNewswire News Roomยท2024-08-27 15:13Core Viewpoint - A lawsuit has been filed against Orthofix Medical, Inc. for failing to disclose inappropriate conduct by its management team, which misled investors during the Class Period from October 11, 2022, to September 12, 2023 [1][3]. Group 1: Lawsuit Details - The lawsuit claims that Orthofix's management engaged in conduct that violated the company's code of conduct and was inconsistent with its values [3]. - Investors who purchased Orthofix securities during the Class Period can seek to be appointed as lead plaintiff by October 21, 2024 [2]. Group 2: Company Management Changes - On September 12, 2023, Orthofix announced the termination of its CEO, CFO, and Chief Legal Officer for cause, following an investigation that revealed violations of the company's code of conduct [4]. - The stock price of Orthofix fell by $5.62, or 30.2%, closing at $13.01 per share on the day of the announcement [4].